Neuromuscular Blockade Reversal Indication
📧 Sign up to get email alerts when something new happens for Neuromuscular Blockade Reversal Indication.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-06-12EMA Authorised: Sugammadex Mylan (sugammadex sodium) — Mylan Pharmaceuticals Limited
EMA authorises Sugammadex Mylan (sugammadex sodium) for reversal of neuromuscular blockade; new marketing authorisation holder is Mylan Phar…